busulfan and Sarcoma
busulfan has been researched along with Sarcoma in 19 studies
Sarcoma: A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "At our Institute, during the last decade, the incidence of hepatic veno-occlusive disease (HVOD) appears to be on the increase among pediatric patients treated with BU-thiotepa (BU-TTP)-conditioning regimen." | 7.74 | Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen. ( Amoroso, L; Benhamou, E; Cacchione, A; Couanet, DV; Hartmann, O; LeMaitre, A; Simonnard, N, 2008) |
| " This study evaluates the toxicity of escalating doses of topotecan alone or in combination with thiotepa or treosulfan." | 5.39 | Escalating topotecan in combination with treosulfan has acceptable toxicity in advanced pediatric sarcomas. ( Bauer, F; Burdach, S; Filipiak-Pittroff, B; von Luettichau, I; Wawer, A, 2013) |
| "At our Institute, during the last decade, the incidence of hepatic veno-occlusive disease (HVOD) appears to be on the increase among pediatric patients treated with BU-thiotepa (BU-TTP)-conditioning regimen." | 3.74 | Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen. ( Amoroso, L; Benhamou, E; Cacchione, A; Couanet, DV; Hartmann, O; LeMaitre, A; Simonnard, N, 2008) |
| "In this study we have used a standardised ATP-based tumour chemosensitivity assay (ATP-TCA) to measure the activity of gefitinib alone or in combination with different cytotoxic drugs (cisplatin, gemcitabine, oxaliplatin and treosulfan) against a variety of solid tumours (n = 86), including breast, colorectal, oesophageal and ovarian cancer, carcinoma of unknown primary site, cutaneous and uveal melanoma, non-small cell lung cancer (NSCLC) and sarcoma." | 3.72 | The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours. ( Cree, IA; Di Nicolantonio, F; Glaysher, S; Johnson, P; Knight, LA; Mercer, S; Sharma, S; Whitehouse, P, 2004) |
| " This study evaluates the toxicity of escalating doses of topotecan alone or in combination with thiotepa or treosulfan." | 1.39 | Escalating topotecan in combination with treosulfan has acceptable toxicity in advanced pediatric sarcomas. ( Bauer, F; Burdach, S; Filipiak-Pittroff, B; von Luettichau, I; Wawer, A, 2013) |
| "Busulfan 16 mg/kg was paired with cyclophosphamide 200 mg/kg (BuCY) or with etoposide 60 mg/kg (Bu-Vp)." | 1.29 | Busulfan-containing pre-transplant regimens for the treatment of solid tumors. ( Adler, SS; Feingold, JM; Ghalie, R; Kaizer, H; Korenblit, AD; Manson, S; Pruett, J; Reynolds, J; Valentino, LA, 1994) |
Research
Studies (19)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (68.42) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bauer, F | 1 |
| Filipiak-Pittroff, B | 1 |
| Wawer, A | 1 |
| von Luettichau, I | 1 |
| Burdach, S | 1 |
| Cacchione, A | 1 |
| LeMaitre, A | 1 |
| Couanet, DV | 1 |
| Benhamou, E | 1 |
| Amoroso, L | 1 |
| Simonnard, N | 1 |
| Hartmann, O | 1 |
| Thall, PF | 1 |
| Wathen, JK | 1 |
| Bekele, BN | 1 |
| Champlin, RE | 1 |
| Baker, LH | 1 |
| Benjamin, RS | 1 |
| KANO, K | 1 |
| TANAKA, T | 1 |
| BRAMBILLA, G | 1 |
| BALDINI, L | 1 |
| PITNEY, WR | 1 |
| CHU, TH | 1 |
| WU, YI | 1 |
| STANISLAVSKAIA, MS | 1 |
| PRESNOV, MA | 1 |
| ORIGENES, ML | 1 |
| BEATTY, EC | 1 |
| BRUBAKER, C | 1 |
| HAMMOND, D | 1 |
| HARTMANN, JR | 1 |
| SHORE, N | 1 |
| WILLIAMS, KO | 1 |
| HUTCHISON, JL | 1 |
| HAYASHI, S | 1 |
| UEKI, H | 1 |
| KOMIYA, J | 1 |
| MORROW, LB | 1 |
| ANDERSON, RE | 1 |
| CLIFFORD, P | 1 |
| BHARDWAJ, BV | 1 |
| WHITTAKER, LR | 1 |
| Knight, LA | 1 |
| Di Nicolantonio, F | 1 |
| Whitehouse, P | 1 |
| Mercer, S | 1 |
| Sharma, S | 1 |
| Glaysher, S | 1 |
| Johnson, P | 1 |
| Cree, IA | 1 |
| Ghalie, R | 1 |
| Reynolds, J | 1 |
| Valentino, LA | 1 |
| Manson, S | 1 |
| Korenblit, AD | 1 |
| Feingold, JM | 1 |
| Adler, SS | 1 |
| Pruett, J | 1 |
| Kaizer, H | 1 |
| Yonemoto, T | 1 |
| Tatezaki, S | 1 |
| Ishii, T | 1 |
| Satoh, T | 1 |
| Fefer, A | 1 |
| McNutt, DR | 1 |
| Fudenberg, HH | 1 |
Reviews
1 review available for busulfan and Sarcoma
| Article | Year |
|---|---|
Adoptive tumor immunotherapy in mice as an adjunct to whole-body x-irradiation and chemotherapy. A review.
Topics: Animals; Antigens, Neoplasm; Bone Marrow Cells; Bone Marrow Transplantation; Busulfan; Cyclophospham | 1973 |
Other Studies
18 other studies available for busulfan and Sarcoma
| Article | Year |
|---|---|
Escalating topotecan in combination with treosulfan has acceptable toxicity in advanced pediatric sarcomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool | 2013 |
Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen.
Topics: Adolescent; Antineoplastic Agents; Brain Neoplasms; Busulfan; Carboplatin; Child; Child, Preschool; | 2008 |
Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes.
Topics: Antineoplastic Agents; Bayes Theorem; Benzamides; Bone Marrow Transplantation; Busulfan; Clinical Tr | 2003 |
[Effect of GT-41 (Myleran) on tumor cells of the MTK-sarcoma III].
Topics: Animals; Busulfan; Glycols; Neoplasms; Sarcoma; Sarcoma, Experimental | 1955 |
[Effect of the association of 6-mercaptopurine-chlorambucil and 6-mercaptopurine-myleran on the growth of Galliera sarcoma in the rat].
Topics: Animals; Antineoplastic Agents; Busulfan; Chlorambucil; Mercaptopurine; Neoplasms; Rats; Sarcoma | 1960 |
Chemotherapy of malignant disease. II. Diseases of lymphoid tissue and bone marrow.
Topics: Adrenal Cortex Hormones; Aged; Bone Marrow; Busulfan; Chlorambucil; Cyclophosphamide; Hodgkin Diseas | 1962 |
[STUDIES ON ANTITUMOR DRUGS. III. THE USE OF IN VITRO CULTURE OF YOSHIDA ASCITES SARCOMA CELLS IN SCREENING ANTITUMOR SUBSTANCES].
Topics: Animals; Antineoplastic Agents; Ascites; Busulfan; Chemical Phenomena; Chemistry; In Vitro Technique | 1963 |
[EXPERIMENTAL STUDIES ON THE ANTINEOPLASTIC EFFECT OF OLIVOMYCIN IN ASSOCIATION WITH SOME SYNTHETIC CYTOSTATIC DRUGS IN CROCKER'S SARCOMA].
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antineoplastic Agents; Busulfan; Cytost | 1963 |
HISTOLOGICAL AND HISTOCHEMICAL DATA ON THE PROCESS OF REGRESSION OF EXPERIMENTAL TUMOURS INDUCED BY ALKYLATING AGENTS.
Topics: Alkaline Phosphatase; Alkylating Agents; Animals; Antineoplastic Agents; Aziridines; Busulfan; Carci | 1964 |
TRIAL OF HYDROXYUREA (NSC-32065) IN CANCER IN CHILDREN.
Topics: Antineoplastic Agents; Busulfan; Child; Cyclophosphamide; Dactinomycin; Humans; Hydroxyurea; Leukemi | 1964 |
THE MANAGEMENT OF LEUKEMIA AND LYMPHOMA.
Topics: Adrenal Cortex Hormones; Busulfan; Chlorambucil; Cortisone; Cyclophosphamide; Hodgkin Disease; Human | 1964 |
STUDIES ON ANTITUMOR SUBSTANCES. IV. ANTITUMOR EFFECT OF DIMETHANESULFONYL THIOALKANES.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Antineoplastic Agents; Busulfan; Carbohydrate Metab | 1964 |
ACTIVE TUBERCULOSIS IN LEUKEMIA. MALIGNANT LYMPHOMA AND MYELOFIBROSIS.
Topics: Alkylating Agents; Aminopterin; Busulfan; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leu | 1965 |
INTENSIVE NITROGEN MUSTARD THERAPY WITH ABDOMINAL AORTIC OCCLUSION IN NASOPHARYNGEAL CARCINOMA.
Topics: Adenocarcinoma; Antineoplastic Agents; Aorta; Aorta, Abdominal; Busulfan; Carcinoma; Carcinoma, Squa | 1965 |
The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours.
Topics: Adenocarcinoma; Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Breast Neopl | 2004 |
Busulfan-containing pre-transplant regimens for the treatment of solid tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brea | 1994 |
[High-dose chemotherapy with autologous peripheral blood stem cell transplantation (PBSCT) for refractory bone and soft tissue sarcomas].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Child; | 1999 |
Disseminated scotochromogen infection and unusual myeloproliferative disorder. Report of a case and review of the literature.
Topics: Adolescent; Adult; Aged; Autopsy; Busulfan; Child; Child, Preschool; Chlorambucil; Female; Humans; L | 1971 |